Literature DB >> 2236756

Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta 2-adrenergic agonist.

L G McAlpine1, N C Thomson.   

Abstract

The prophylaxis of exercise-induced asthma with inhaled formoterol (12 micrograms) was compared with inhaled salbutamol (200 micrograms) and placebo in 12 patients with atopic asthma. Both drugs produced equal bronchodilation 2 and 4 h after administration. Both drugs protected equally against exercise-induced bronchoconstriction 2 h after administration; at 4 h, formoterol gave undiminished protection from that seen at 2 h while salbutamol was no more effective than placebo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236756     DOI: 10.1016/s0954-6111(08)80056-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  11 in total

Review 1.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 2.  Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  D Faulds; L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

3.  Prevention of exercise induced asthma by inhaled salmeterol xinafoate.

Authors:  C P Green; J F Price
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

Review 4.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 5.  Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

Authors:  B J Lipworth; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

6.  Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.

Authors:  B T van den Berg; R T Louwerse; G J Luiken; R E Jonkers; C J van Boxtel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

7.  Comparison of the Bronchodilator Effect of Inhaled Short- and Long-Acting beta(2)-Agonists in Children with Bronchial Asthma: A Randomised Trial.

Authors:  M Verini; A Verrotti; R Greco; F Chiarelli
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.

Authors:  A R Kompa; P Molenaar; R J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

9.  Trigger factors in asthma and chronic obstructive pulmonary disease: a single-centre cross-sectional survey.

Authors:  Kay Choong See; Jason Phua; Tow Keang Lim
Journal:  Singapore Med J       Date:  2015-11-25       Impact factor: 1.858

10.  Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.

Authors:  James P Kemp
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.